Cryopreservation of Ovarian Tissue

Description

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Conditions

Cancer, Risk of Premature Ovarian Failure, Fertility Preservation

Talk to us

Study Overview

On this page

Study Details

Study overview

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation

Cryopreservation of Ovarian Tissue

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, New York, United States, 10021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Females 0-45 years of age who are premenopausal
  • * Treatment plan that will likely result in premature menopause or premature ovarian failure
  • * This includes patients receiving:
  • * Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
  • * Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
  • * Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
  • * Previous treatment for cancer is acceptable if patient still has ovarian function
  • * Patient is medically stable enough to undergo surgery (cleared for anesthesia)
  • * Patients not meeting the above criteria
  • * Patients who have not received medical clearance from their physicians to undergo surgery
  • * Patients already experiencing menopause.

Ages Eligible for Study

to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Weill Medical College of Cornell University,

Glenn Schattman, MD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

2025-10-31